First author* | Publication year | Number of patients | Population | Modalities compared to MRI |
---|---|---|---|---|
Hundley | 1998 | 35 | Patients referred for evaluation of LV function | 2D-echo (non-contrast), 2D-echo (contrast) |
Schmidt | 1999 | 25 | 4 normal volunteers; 21 cardiac patients | 3D-echo (non-contrast) |
Chuang | 2000 | 35 | 10 healthy adult volunteers; 25 patients with dilated cardiomyopathy | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Qin | 2000 | 16 | Patients with normal LV | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Chuang | 2001 | 24 | 12 obese/overweight patients and 12 lean patients | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Schalla | 2001 | 34 | Cardiac patients | 2D-echo (non-contrast) |
Mannaerts | 2003 | 17 | 7 healthy volunteers and 20 patients with: hypertrophic cardiomyopathy, aortic or mitral regurgitation, or AMI | 3D-echo (non-contrast) |
Zeidan | 2003 | 15 | Healthy volunteers | 3D-echo (non-contrast) |
Jenkins | 2004 | 50 | Patients referred to the echo laboratory | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Malm | 2004 | 87 | Patients referred to the cardiology department | 2D-echo (non-contrast), 2D-echo (contrast) |
Caiani | 2005 | 46 | Patients with normal LV function | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Corsi | 2005 | 16 | Normal volunteers and patients with CAD, dilated cardiomyopathy, valvular disease | 3D-echo (non-contrast) |
Lim | 2005 | 36 | Stable patients with post-AMI | 2D-echo (non-contrast), 2D-echo (contrast) |
Wang | 2005 | 11 | Patients with chronic CAD | 2D-echo (non-contrast) |
Chan | 2006 | 30 | Patients with previous AMI with altered shape and wall-motion abnormalities | 3D-echo (non-contrast) |
Dewey | 2006 | 30 | Patients with suspected CAD | 2D-echo (non-contrast) |
Jenkins | 2006 | 110 | Patients referred to the echo laboratory for measurement of LV volumes and EF | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Krenning | 2006 | 15 | Male patients with a history of AMI and various degrees of wall-motion abnormalities | 3D-echo (non-contrast) |
Liew | 2006 | 32 | Outpatient cardiac clinic patients with known CAD | 2D-echo (non-contrast), MDCT 64-slice |
Malm | 2006 | 50 | Patients submitted to echocardiography were enrolled | 2D-echo (non-contrast), 2D-echo (nontrast) |
Nigri | 2006 | 70 | 35 patients with aortic stenosis and 35 with aortic regurgitation with surgical indication | 2D-echo (non-contrast) |
Nikitin | 2006 | 64 | 40 cardiac patients with LVEF <45%, 14 with EF >45% and 10 normal volunteers | 3D-echo (non-contrast) |
Sugeng | 2006 | 31 | Patients referred for clinically indicated CT angiography | 3D-echo (non-contrast) |
Brodoefel | 2007 | 20 | Patients with chronic CAD | Dual source CT 2×32 |
Demir | 2007 | 21 | Patients with known or suspected CAD | 2D-echo (non-contrast) |
Giakoumis | 2007 | 135 | Patients with thalassaemia major attending an outpatient clinic | 2D-echo (non-contrast) |
Jenkins | 2007 | 50 | Patients with LV dysfunction due to previous AMI | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Jenkins | 2007 | 30 | Patients referred to the echo laboratory for measurement of LV volumes and EF | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Krenning | 2007 | 39 | Patients referred for routine evaluation of cardiac function after AMI | 3D-echo (non-contrast) |
Qi | 2007 | 58 | 44 patients with various cardiac disorders referred for clinical MRI studies and 14 normal patients | 3D-echo (non-contrast) |
Schlosser | 2007 | 21 | Patients referred for CTCA | MDCT 64-slice |
Soliman | 2007 | 53 | Patients with a cardiomyopathy and adequate 2D image quality | 3D-echo (non-contrast) |
Bastarrika | 2008 | 12 | Patients heart transplant recipients | Dual source CT 32×2 |
Busch | 2008 | 15 | Mixed population of patients | Dual source CT 32×2 |
Chukwu | 2008 | 69 | 35 with normal LV systolic function and 34 with AMI and depressed LV function | 2D-echo (non-contrast), 3D-echo (non-contrast) |
Leonardi | 2008 | 24 | Patients with thalassaemia | 2D-echo (non-contrast) |
Mor-Avi | 2008 | 92 | Patients referred for CMR evaluation of LV size and function | 3D-echo (non-contrast) |
Pouleur | 2008 | 83 | 20 volunteers and 63 patients with heart disease including aortic valve disease, severe mitral regurgitation and previous AMI | 3D-echo (non-contrast) |
Puesken | 2008 | 28 | Patients with known/suspected CAD | MDCT 64-slice |
Rutten | 2008 | 78 | Mild to moderate patients with COPD with and without heart failure | 2D-echo (non-contrast) |
Soliman | 2008 | 24 | 17 patients with impaired LV systolic function due to CAD or idiopathic dilated cardiomyopathy | 3D-echo (non-contrast) |
Wu | 2008 | 41 | Mixed population of patients | MDCT 64-slice |
Akram | 2009 | 20 | Patients with suspected CAD | MDCT 64-slice |
Garcia-Alvarez | 2009 | 65 | Patients with first STEMI admitted to a tertiary care hospital and reperfused within 12 h of symptom onset | 2D-echo (non-contrast) |
Gardner | 2009 | 47 | Patients with AMI greater than 6 weeks previously and scheduled for imaging evaluation | 2D-echo (non-contrast) |
Gjesdal | 2009 | 61 | Healthy controls and patients with acute STEMI and treated with PCI | 2D-echo (non-contrast) |
Guo | 2009 | 51 | Patients with mitral regurgitation confirmed by 2D-echo and colour Doppler | 2D-echo (non-contrast), MDCT 64-slice |
Jenkins | 2009 | 50 | Patients with past AMI who underwent echocardiographic assessment of LV volume and function | 2D-echo (non-contrast), 2D-echo (contrast), 3D-echo (non-contrast) |
Nowosielski | 2009 | 52 | Patients with first AMI and PCI | 2D-echo (non-contrast) |
Sarwar | 2009 | 21 | Patients with STEMI | MDCT 64-slice |
Abbate | 2010 | 10 | Patients with ST-segment elevation AMI | 2D-echo (non-contrast) |
Claver | 2010 | 43 | Unselected patients who underwent CMR; mixed cardiac pathologies | 3D-echo (non-contrast) |
Palumbo | 2010 | 181 | Patients with suspected CAD, indexed volumes | MDCT 64-slice |
Whalley | 2010 | 25 | Patients with at least moderate MR due to MV prolapse | 2D-echo (non-contrast) |
De Jonge | 2011 | 26 | Patients referred for CTCA | Dual source CT 2×32 |
Arraiza | 2012 | 25 | Patients heart transplant recipients | 2D-echo (contrast), dual source CT 2×32 |
Bak | 2012 | 111 | Patients referred for CTCA before valve surgery | 2D-echo (non-contrast), dual source 2×32 |
Brodoefel | 2012 | 20 | Patients with known or suspected CAD | Dual source CT 2×32 |
Coon | 2012 | 18 | Patients with CAD, dilated cardiomyopathy, post-AMI, aortic abnormalities and mitral valve disease | 3D-echo (non-contrast), 3D-echo (contrast) |
Fuchs | 2012 | 53 | Patients with previous AMI | MDCT 64-slice |
Greupner | 2012 | 36 | Patients referred for CTCA | 2D-echo (non-contrast), 3D-echo (non-contrast), MDCT 64-slice |
Lee | 2012 | 30 | Patients who had undergone clinically indicated, routine CCTA studies | MDCT 64-slice |
Li | 2012 | 72 | Mixed population of cardiac patients | 2D-echo (non-contrast) |
Maffei | 2012 | 79 | Patients referred for CTCA, indexed volumes | MDCT 64-slice |
Takx | 2012 | 20 | Patients with known or suspected CAD | Dual source CT 2×32 |
Total | 1998-2013 | 2888 | 2D Echo (NC): 32 studies/1663 examinations 2D Echo (C): 6 studies/283 examinations 3D Echo (NC): 27 studies/1137 examinations 3D Echo (C): 3 studies/107 examinations MDCT: 20 studies/842 examinations | 50 Echo and 20 CT (5 of these included echo and CT) |
2D, two-dimensional echo; AMI, acute myocardial infarction; C, contrast; CAD, coronary artery disease; CMR, cardiac MR; COPD, chronic obstructive pulmonary disease; CTCA, CT coronary angiography; EF, ejection fraction; LV, left ventricular; LVEF, left ventricular ejection fraction; MDCT, multidetector CT; MV, mitral valve; NC, non-contrast; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction.
*See online supplementary file for citations.